Topics
- COVID-19 (102)
- Advertising (74)
- COVID-19 vaccines (63)
- Prescription medicines (29)
- Medical devices (20)
- Regulatory compliance (18)
- Alert/Advisory (14)
- Medicines safety (9)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Medicines (5)
- OTC medicines (3)
- Labelling and packaging (2)
- Shortages (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biologicals (1)
- Medicinal cannabis hub (1)
- Safety (1)
- Scheduling (1)
- Unapproved therapeutic goods (1)
Collection content
294 result(s) found, displaying 31 to 40
- Media releasesTGA grants provisional determination for sabizabulin for the treatment of COVID-19TGA grants provisional determination for sabizabulin for the treatment of COVID-19
- NewsCOVID-19 vaccine: SPIKEVAX (elasomeran)The TGA has provisionally approved Moderna's COVID-19 vaccine, SPIKEVAX, for use as a booster dose in individuals aged 12 years and older.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 11-08-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA commences evaluation of Pfizer's COVID-19 vaccine (COMIRNATY) for children aged 6 months to less than 5 yearsTGA commences evaluation of Pfizer's COVID-19 vaccine (COMIRNATY) for children aged 6 months to less than 5 years
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 28-07-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 14-07-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- NewsCOVID-19 vaccine provisional determinationsCOVID-19 vaccines that have received a provisional determination from the TGA.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 30-06-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 23-06-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesHough Pharma Pty Ltd fined $106,560 for allegedly failing to provide information to demonstrate adequate performance of three COVID-19 rapid antigen tests and for allegedly failing to provide appropriate customer supportThe TGA has issued eight (8) infringement notices totalling $106,560 to Hough Pharma Pty Ltd for allegedly failing to provide information to the TGA to demonstrate the safety and performance of three COVID-19 RATs.